CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Revealix

Were leading a fundamental rethinking of how diabetic limb complications are detected and monitored: noninvasive, mobile & point-of-care. Techstars backed!

Expert-Med

Expert-Med is a Ormond Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quality Packaging L L C

Quality Packaging L L C is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, NJ. To find more information about Quality Packaging L L C, please visit www.qpsiusa.com

Aware Recovery Care

Our mission at Aware Recovery Care is to help people affected by addiction “Recover Where You Live”. At Aware Recovery Care, we transform the home into a treatment center, delivering innovative addiction services to those in need, where they live. We treat addiction like a chronic illness, and our groundbreaking and evidence-based treatment approach provides comprehensive care from a multidisciplinary team of clinicians led by an Addiction Psychiatrist, a Family Systems Therapist, and a Registered Nurse. And with the help of a Certified Recovery Advisor, we help our clients learn new skills and daily habits required to maintain abstinence, while remaining amongst family and friends in their community, thereby avoiding the oftentimes difficult return home from traditional treatment options. Privacy and anonymity are respected, and dignity is preserved as we provide care that is discreet and effective. Authenticity, empathy, purpose, and thoughtfulness are at the heart of everything we do, and we seek deeply passionate people who are committed to immersing themselves in our mission. Those who are up for the task will be rewarded with rewarding mission-oriented workdays, and a voice at the table helping to build a transformational business entering a hypergrowth stage. Come join us as we create a preferred destination for top talent in the Healthcare community and set a new standard for the treatment of SUD. In early 2021, Aware received an investment by Health Enterprise Partners (HEP), a growth equity firm whose investors include some of the largest health systems and health insurance plans in the United States. Aware now operates in nine states (CT, MA, RI, NH, ME, VA, OH, IN, FL) and is poised for hyper-growth and national expansion in partnership with established national and regional payors, employers, and other stakeholders.

CoreLink Administrative Solutions

CoreLink Administrative Solutions was launched on January 1, 2009, as a new concept in health care benefits technology. We provide the technology that allows multiple companies to share common core systems and services, resulting in significant cost savings, gains in efficiency and improved capabilities to provide enhanced services. CoreLink is a long-term IT investment funded by Blue Cross Blue Shield of Nebraska and Blue Cross Blue Shield of North Dakota. Working together, the technology experts have built an infrastructure capitalizing on the strengths and experience of both Plans. This investment provides the means to efficiently address the ongoing changes in the health care environment and challenges posed by regulatory requirements, which can add significant costs to Plan operations.